Patrick Mc Grath
About Patrick Mc Grath
Patrick Mc Grath is the Senior Manager of Microbiology CAR-T Cell Therapy Development and Operations at Bristol-Myers Squibb in New Jersey, with over 20 years of experience in microbiology and quality assurance.
Current Role at Bristol-Myers Squibb
Patrick Mc Grath currently serves as the Senior Manager, Microbiology Car-T Cell Therapy Development and Operations at Bristol-Myers Squibb in New Jersey. He has held this position since July 2019. In this role, he is involved in the development and operational aspects of CAR-T cell therapy, leveraging his extensive background in microbiology.
Previous Experience at Ortho Clinical Diagnostics
Before joining Bristol-Myers Squibb, Mc Grath worked at Ortho Clinical Diagnostics. From 2018 to 2019, he was the Manufacturing Quality and Validation Manager, where he was responsible for overseeing manufacturing quality systems and validation processes. Prior to that, he served as the Quality Assurance Manager-Microbiology from 2014 to 2018, focusing on quality assurance in microbiology.
Career at Colgate-Palmolive and Avon
Mc Grath has also worked with other leading companies in his field. From 2011 to 2014, he was a Technical Associate in Global Microbiology at Colgate-Palmolive in Piscataway, NJ. At Avon, he held two roles: from 2008 to 2010, he was a Program Manager, and from 2004 to 2008, he worked as a Senior Research Microbiologist, both positions based in Suffern, NY.
Educational Background
Patrick Mc Grath holds a Master's degree in Biology, General from Seton Hall University, where he studied from 2000 to 2003. He also has a Bachelor's degree in Biology, General from the University of Northern Colorado, earned over a five-year period from 1993 to 1998.
Expertise in Quality Assurance and Microbiology
With more than 20 years of experience, Mc Grath has a comprehensive background in microbiology and quality assurance. He has strong expertise in GMP (Good Manufacturing Practice) compliance and extensive experience in quality auditing and validation within the medical device industry. He has also been actively involved in various R&D projects and has collaborated with the U.S. Food and Drug Administration (FDA) in his different roles.